WHG
CRSP icon

Westwood Holdings Group’s CRISPR Therapeutics CRSP Stock Holding History

Westwood Holdings Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Sell
20,580
-873
-4% -$46K 0.01% 357
2026
Q1 		$1.02M Sell
21,453
-2,462
-10% -$130K 0.01% 349
2025
Q4 		$1.25M Sell
23,915
-1,204
-5% -$72.1K 0.01% 365
2025
Q3 		$1.63M Sell
25,119
-5,395
-18% -$310K 0.01% 352
2025
Q2 		$1.48M Sell
30,514
-8,552
-22% -$331K 0.01% 357
2025
Q1 		$1.33M Sell
39,066
-14,036
-26% -$595K 0.01% 346
2024
Q4 		$2.09M Buy
53,102
+8,120
+18% +$383K 0.02% 317
2024
Q3 		$2.11M Buy
44,982
+7,607
+20% +$386K 0.01% 329
2024
Q2 		$2.02M Buy
37,375
+22,516
+152% +$1.3M 0.01% 315
2024
Q1 		$1.01M Sell
14,859
-30,473
-67% -$2.18M 0.01% 358
2023
Q4 		$2.84M Sell
45,332
-129,856
-74% -$7.18M 0.02% 282
2023
Q3 		$7.95M Buy
175,188
+85,158
+95% +$4.4M 0.07% 204
2023
Q2 		$5.05M Sell
90,030
-3,509
-4% -$199K 0.05% 249
2023
Q1 		$4.23M Buy
93,539
+63,360
+210% +$3.08M 0.04% 260
2022
Q4 		$1.23M Sell
30,179
-2,150
-7% -$114K 0.01% 336
2022
Q3 		$2.11M Sell
32,329
-9,945
-24% -$721K 0.03% 260
2022
Q2 		$2.57M Buy
42,274
+23,582
+126% +$1.39M 0.03% 269
2022
Q1 		$1.17M Buy
18,692
+9,439
+102% +$593K 0.01% 345
2021
Q4 		$701K Sell
9,253
-10,040
-52% -$877K 0.01% 366
2021
Q3 		$2.16M Buy
19,293
+9,310
+93% +$1.17M 0.02% 280
2021
Q2 		$1.62M Buy
+9,983
New +$1.21M 0.02% 307

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Westwood Holdings Group's CRSP Position: Q2 2026 in Review

Westwood Holdings Group reduced its CRISPR Therapeutics (CRSP) stake by 4.1% in Q2 2026, selling an estimated $46K and leaving 20,580 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #357.

Westwood Holdings Group first reported a position in CRSP in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.95M in Q3 2023. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Westwood Holdings Group held 20,580 shares of CRISPR Therapeutics worth $1.12M as of Q2 2026.
  • Westwood Holdings Group sold 873 CRISPR Therapeutics shares in Q2 2026, an estimated $46K.
  • CRISPR Therapeutics made up 0.01% of Westwood Holdings Group's portfolio in Q2 2026, its #357 holding.
  • Westwood Holdings Group first reported a position in CRISPR Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Westwood Holdings Group's CRISPR Therapeutics position peaked at $7.95M in Q3 2023.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Westwood Holdings Group's 13F filing for Q2 2026, filed 14 Aug 2026.